The U.S. will reportedly purchase 500 million Pfizer doses, donate them worldwide


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
The United States is about to ramp up its global COVID-19 vaccine donation efforts, three people familiar with the Biden administration's plans told The Washington Post.
Biden will reportedly announce during a Group of Seven meeting in the United Kingdom this week that the U.S. will purchase 500 million doses of the Pfizer-BioNTech vaccine and designate them specifically for worldwide distribution over the next year. The White House had previously said it would share 80 million doses with other countries by the end of June, so this appears to be a significant development as the gap in vaccine accessibility between rich and poor countries grows more glaring.
CNN's Kaitlin Collins reports that about 40 percent of the future doses will go out this year, and The Associated Press notes the remaining doses are slated for delivery in the first half of 2022. Read more at The Washington Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published
-
The NHS plan for virtual wards to beat winter crisis
feature Patients with respiratory infections to be given wearable devices that allow doctors to monitor them at home
By The Week Staff Published